Quarterly report · Q1
4323.TEDINET S100RO43
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.6bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥23.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥122m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥261m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥134m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥290m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥134m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥290m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥62m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥224m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥63m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥231m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥18.3bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥17.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥16.4bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.8bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.5bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥10.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.2bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.0bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.3bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥138m | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥542m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥64m | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥405m | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥281m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥266m | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥5.05 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.5 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.26 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.2% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥47m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥628m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥825m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥807m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥19m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥104m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥415m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥415m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥961m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥960m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥407,000 |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥147m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥5.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥47m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥750m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥513m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥688m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥682m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥6m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥119m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥319m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥319m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥11m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥865m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥865m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥67,000 |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥132m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥26m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥774m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 470
| Item | Context | Value | Unit |
|---|---|---|---|
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant | Text · Plus | |
| Notes quarterly consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |